Webinars

Time: 8AM PST | 11AM EST | 5PM CET Date: February 22, 2024 Title: Advancing Therapeutic Approaches for Erythropoietic Protoporphyria Description: Currently, no curative treatment is available for the rare disease erythropoietic protoporphyria (EPP). The genetic background of EPP is well understood; a loss-of-function mutation on ...

Time: 8AM PST | 11AM EST | 5PM CET Date: January 25, 2024 Title: siRNA therapy for ex vivo treatment of stem cell grafts and/or donor lymphocytes Description: Allogeneic T cells represent the most potent treatment for hematopoietic malignancies such es leukemia. However, after interaction with ...

Time: 8AM PST | 11AM EST | 5PM CET Date: October 12, 2023 This presentation will cover defining the key hurdles for non-viral DNA delivery, innate immune stimulation, and delivery to post-mitotic nuclei, as well as strategies to address these challenges. ...

Time: 8AM PST | 11AM EST | 5PM CET Date: Thursday, September 14, 2023 Webinar title: Assessing antisense oligonucleotide delivery to the brain What is your research about? Amy Byrnes, PhD, focuses her research on understanding how delivery vehicles impact antisense oligonucleotide (ASO) activity and biodistribution. To this ...

Time: 8AM PST / 11AM EST / 5PM CET Date: August 3, 2023 Aro Biotx is focused on developing Centyrin-siRNA conjugates for treatment of extrahepatic genetic diseases. Our lead program employs a CD71 Centyrin for targeting to muscle together with an siRNA for glycogen synthase 1 for the ...

Time: 8AM PST / 11AM EST / 5PM CET Date: July 6, 2023 Speakers: Shalini Andersson, PhD Vice President of Oligonucleotide Discovery AstraZeneca View Bio